Evidence map›Paper›PMID 32203711›Full record

ReviewThe Lancet. Respiratory medicine2020

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.

Kollengode Ramanathan, David Antognini, Alain Combes, Matthew Paden, Bishoy Zakhary, Mark Ogino, Graeme MacLaren, Daniel Brodie, Kiran Shekar

Open access · bronzeAbstract readReview
In one paragraph

Review in The Lancet. Respiratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 273 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
273citing papers in PubMed, 9 pooled it
43.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

273 citing papers in PubMed, 9 syntheses or guidelines pooled it, 548 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Guideline
  8. Guideline
  9. Pooled it
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

213 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 4 countries.

Kollengode RamanathanCardiothoracic Intensive Care Unit, National University Hospital, National University of Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Bond University, Robina, QLD, Australia.
David AntogniniUniversity of Queensland, Brisbane, QLD, Australia.
Alain CombesInstitute of Cardiometabolism and Nutrition, University of Paris, Paris, France; Medical Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.
Matthew PadenDepartment of Pediatrics, Emory University, Atlanta, GA, USA.
Bishoy ZakharyDivision of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR, USA.
Mark OginoDepartment of Paediatrics, Division of Neonatology, Nemours Alfred I duPont Hospital for Children, Wilmington, DE, USA; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Graeme MacLarenCardiothoracic Intensive Care Unit, National University Hospital, National University of Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Paediatric Intensive Care Unit, The Royal Children's Hospital, University of Melbourne, Melbourne, VIC, Australia.
Daniel BrodieColumbia University College of Physicians and Surgeons, New York, NY, USA; Centre for Acute Respiratory Failure, New York-Presbyterian Hospital, New York, NY, USA.
Kiran ShekarBond University, Robina, QLD, Australia; University of Queensland, Brisbane, QLD, Australia; Adult Intensive Care Services, The Prince Charles Hospital, Metro North Hospital and Health Service, Brisbane, QLD, Australia; Critical Care Research Group, Centre of Research Excellence for Advanced Cardio-respiratory Therapies Improving OrgaN Support, Brisbane, QLD, Australia. Electronic address: kiran.shekar@health.qld.gov.au.
National University Hospital · SGBond University · AUColumbia University · USEmory University · USOregon Health & Science University · USThomas Jefferson University · USUniversité Paris Cité · FRUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

WHO interim guidelines recommend offering extracorporeal membrane oxygenation (ECMO) to eligible patients with acute respiratory distress syndrome (ARDS) related to coronavirus disease 2019 (COVID-19). The number of patients with COVID-19 infection who might develop severe ARDS that is refractory to maximal medical management and require this level of support is currently unknown. Available evidence from similar patient populations suggests that carefully selected patients with severe ARDS who do not benefit from conventional treatment might be successfully supported with venovenous ECMO. The need for ECMO is relatively low and its use is mostly restricted to specialised centres globally. Providing complex therapies such as ECMO during outbreaks of emerging infectious diseases has unique challenges. Careful planning, judicious resource allocation, and training of personnel to provide complex therapeutic interventions while adhering to strict infection control measures are all crucial components of an ECMO action plan. ECMO can be initiated in specialist centres, or patients can receive ECMO during transportation from a centre that is not specialised for this procedure to an expert ECMO centre. Ensuring that systems enable safe and coordinated movement of critically ill patients, staff, and equipment is important to improve ECMO access. ECMO preparedness for the COVID-19 pandemic is important in view of the high transmission rate of the virus and respiratory-related mortality.

Indexed as

BetacoronavirusCommunicable Diseases, EmergingCoronavirus InfectionsCOVID-19Extracorporeal Membrane OxygenationHumansPandemicsPneumonia, ViralPractice Guidelines as TopicRespiratory Distress SyndromeSARS-CoV-2

Identifiers

PMID32203711
PMCPMC7102637
OpenAlexW3012186724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.